1. Home
  2. ZLAB vs HLIO Comparison

ZLAB vs HLIO Comparison

Compare ZLAB & HLIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$26.49

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Helios Technologies Inc.

HLIO

Helios Technologies Inc.

HOLD

Current Price

$68.85

Market Cap

2.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZLAB
HLIO
Founded
2013
1970
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.6B
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
ZLAB
HLIO
Price
$26.49
$68.85
Analyst Decision
Strong Buy
Buy
Analyst Count
5
6
Target Price
$49.60
$66.17
AVG Volume (30 Days)
781.7K
253.2K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
0.72%
EPS Growth
38.46
23.93
EPS
N/A
1.25
Revenue
$460,156,000.00
$200,727,000.00
Revenue This Year
$9.75
$3.67
Revenue Next Year
$26.03
$5.00
P/E Ratio
N/A
$54.61
Revenue Growth
15.33
N/A
52 Week Low
$15.96
$47.05
52 Week High
$34.72
$95.05

Technical Indicators

Market Signals
Indicator
ZLAB
HLIO
Relative Strength Index (RSI) 62.61 40.24
Support Level $16.84 $65.83
Resistance Level $27.22 $76.32
Average True Range (ATR) 0.88 1.92
MACD -0.05 0.16
Stochastic Oscillator 80.44 38.50

Price Performance

Historical Comparison
ZLAB
HLIO

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

About HLIO Helios Technologies Inc.

Helios Technologies Inc is an industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic components and systems used to transmit power and control force, speed, and motion. There are two categories based on Hydraulic system architecture: MCT and FCT. The Electronics segment provides complete, fully-tailored display and control solutions for engines, engine-driven equipment, specialty vehicles, therapy baths, and traditional and swim spas. The company generates the majority of its revenue from the Hydraulics segment. Geographically, the company generates key revenue from the Americas region.

Share on Social Networks: